Castration-resistant prostate cancer at high risk of metastasis: enzalutamide has added benefit. For the first time, new data from the PROSPER study show an advantage in overall survival that outweighs the disadvantages in some side effects.
- Study reveals surprising benefit of clonal hematopoiesis in allogeneic transplants
- Researchers adapt cell phone camera for SARS-CoV-2 detection
- Mailman School experts contribute to new Lancet report on health and climate change
- Research reveals how airflow inside a car may affect COVID-19 transmission risk
- No strings attached: maximizing wireless charging efficiency with multiple transmitters